CLL Genome

Study ID Alternative Stable ID Type
EGAS00000000092 Cancer Genomics

Study Description

The Chronic Lymphocytic Leukemia (CLL) Genome Project aims to identify genetic alterations involved in the development and progression of the CLL, which are still unknown, with the objective of generating a comprehensive catalogue of genetic alterations in 500 independent tumours. The CLL Genome Project, as a contributing member of the International Cancer Genome Consortium (ICGC), has the purposes of creating diagnostic tools, discovering therapeutic targets and developing new strategies that will allow a customized therapy for CLL in order to make it more precise and effective. This study consists of two datasets. EGAD00001000023 described in the Nature paper (2011), Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia, and the dataset EGA00001000044 & & EGAD00001000083 described in the Nature (2011) paper, Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Study Datasets 6 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
Recurrent Somatic Mutations in CLL
Illumina Genome Analyzer IIx 11
Recurrent Somatic Mutations in CLL
Illumina Genome Analyzer IIx 212
Recurrent Somatic Mutations in CLL
Illumina Genome Analyzer II,Illumina Genome Analyzer IIx 61
CLL Expression array
Affymetrix GeneChip Human Genome U133 plus 2.0 64
CLL Expression array
Affymetrix snp 6.0 4
CLL Expression Array
GPL570 20

Who archives the data?